MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617074511 A) filed by Rgenta Therapeutics, Inc. on June 16, 2026, for 2,3-Dihydropyrollopyridine Carboxamide Compounds And Methods Of Use Thereof.
Inventors include Yates, Christopher M.; Wager, Travis T.; Bartolozzi, Alessandra; Proudfoot, John Robert; Wynn, Thomas Andrew; and Hamann, Diane.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present disclosure relates to compounds of Formula (I) or subformulas thereof: (I) and pharmaceutically acceptable salts thereof, and their uses in treating PMS1 - associated diseases and disorders.
Disclaimer: Curated by HT Syndication.
